BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34684335)

  • 41. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
    Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
    J Obes; 2013; 2013():296537. PubMed ID: 23401753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pu'erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo lipogenesis in visceral adipose tissue.
    Cai X; Hayashi S; Fang C; Hao S; Wang X; Nishiguchi S; Tsutsui H; Sheng J
    J Gastroenterol; 2017 Dec; 52(12):1240-1251. PubMed ID: 28364190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy.
    Díaz P; Harris J; Rosario FJ; Powell TL; Jansson T
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1569-77. PubMed ID: 26491104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen withdrawal and replacement differentially target liver and adipose tissues in female mice fed a high-fat high-sucrose diet: impact of a chronic exposure to a low-dose pollutant mixture
    Julien B; Pinteur C; Vega N; Vidal H; Naville D; Le Magueresse-Battistoni B
    J Nutr Biochem; 2019 Oct; 72():108211. PubMed ID: 31473509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
    Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
    Yao Y
    Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues.
    Madak-Erdogan Z; Kim SH; Gong P; Zhao YC; Zhang H; Chambliss KL; Carlson KE; Mayne CG; Shaul PW; Korach KS; Katzenellenbogen JA; Katzenellenbogen BS
    Sci Signal; 2016 May; 9(429):ra53. PubMed ID: 27221711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat.
    Zhang H; Liu Y; Wang L; Li Z; Zhang H; Wu J; Rahman N; Guo Y; Li D; Li N; Huhtaniemi I; Tsang SY; Gao GF; Li X
    J Lipid Res; 2013 Feb; 54(2):345-57. PubMed ID: 23175777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS
    Gogiashvili M; Edlund K; Gianmoena K; Marchan R; Brik A; Andersson JT; Lambert J; Madjar K; Hellwig B; Rahnenführer J; Hengstler JG; Hergenröder R; Cadenas C
    Anal Bioanal Chem; 2017 Feb; 409(6):1591-1606. PubMed ID: 27896396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
    Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
    Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.
    Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ
    Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.
    Lu H; Wei M; Zhai Y; Li Q; Ye Z; Wang L; Luo W; Chen J; Lu Z
    J Mol Med (Berl); 2019 Apr; 97(4):473-485. PubMed ID: 30725119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis.
    Ren L; Sun Y; Lu H; Ye D; Han L; Wang N; Daugherty A; Li F; Wang M; Su F; Tao W; Sun J; Zelcer N; Mullick AE; Danser AHJ; Jiang Y; He Y; Ruan X; Lu X
    Circ Res; 2018 Mar; 122(5):730-741. PubMed ID: 29301853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
    Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
    Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
    [No Abstract]   [Full Text] [Related]  

  • 56. Activation of N-methyl-D-aspartate receptor regulates insulin sensitivity and lipid metabolism.
    Huang XT; Yang JX; Wang Z; Zhang CY; Luo ZQ; Liu W; Tang SY
    Theranostics; 2021; 11(5):2247-2262. PubMed ID: 33500723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
    Lee MS; Kim D; Jo K; Hwang JK
    Biochem Biophys Res Commun; 2010 Oct; 401(1):92-7. PubMed ID: 20836990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice.
    Yang JS; Kim JT; Jeon J; Park HS; Kang GH; Park KS; Lee HK; Kim S; Cho YM
    PLoS One; 2010 Nov; 5(11):e13858. PubMed ID: 21079772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
    Romero-Zerbo SY; García-Fernández M; Espinosa-Jiménez V; Pozo-Morales M; Escamilla-Sánchez A; Sánchez-Salido L; Lara E; Cobo-Vuilleumier N; Rafacho A; Olveira G; Rojo-Martínez G; Gauthier BR; González-Mariscal I; Bermúdez-Silva FJ
    Front Endocrinol (Lausanne); 2020; 11():103. PubMed ID: 32210914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.